These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 21116684)

  • 21. Ligand motifs of HLA-DRB5*0101 and DRB1*1501 molecules delineated from self-peptides.
    Vogt AB; Kropshofer H; Kalbacher H; Kalbus M; Rammensee HG; Coligan JE; Martin R
    J Immunol; 1994 Aug; 153(4):1665-73. PubMed ID: 7519208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural diversity of human class II histocompatibility molecules induced by peptide ligands.
    Georges B; Loing E; Neveu R; Melnyk O; Gras-Masse H; Auriault C
    FEBS Lett; 2000 Sep; 481(3):249-54. PubMed ID: 11007973
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural basis of specificity and degeneracy of T cell recognition: pluriallelic restriction of T cell responses to a peptide antigen involves both specific and promiscuous interactions between the T cell receptor, peptide, and HLA-DR.
    Doherty DG; Penzotti JE; Koelle DM; Kwok WW; Lybrand TP; Masewicz S; Nepom GT
    J Immunol; 1998 Oct; 161(7):3527-35. PubMed ID: 9759873
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Promiscuous and allele-specific anchors in HLA-DR-binding peptides.
    Hammer J; Valsasnini P; Tolba K; Bolin D; Higelin J; Takacs B; Sinigaglia F
    Cell; 1993 Jul; 74(1):197-203. PubMed ID: 8334703
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Binding interactions between peptides and proteins of the class II major histocompatibility complex.
    McFarland BJ; Beeson C
    Med Res Rev; 2002 Mar; 22(2):168-203. PubMed ID: 11857638
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ligand exchange of major histocompatibility complex class II proteins is triggered by H-bond donor groups of small molecules.
    Falk K; Lau JM; Santambrogio L; Esteban VM; Puentes F; Rotzschke O; Strominger JL
    J Biol Chem; 2002 Jan; 277(4):2709-15. PubMed ID: 11602608
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Definition of the alpha 2 region of HLA-DR molecules involved in CD4 binding.
    Gaubin M; Houlgatte R; Dettin M; Scarinci C; Martin M; Guardiola J; Di Bello C; Piatier-Tonneau D
    Hum Immunol; 1999 Apr; 60(4):273-81. PubMed ID: 10363718
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular determinants of peptide binding to two common rhesus macaque major histocompatibility complex class II molecules.
    Dzuris JL; Sidney J; Horton H; Correa R; Carter D; Chesnut RW; Watkins DI; Sette A
    J Virol; 2001 Nov; 75(22):10958-68. PubMed ID: 11602736
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MultiRTA: a simple yet reliable method for predicting peptide binding affinities for multiple class II MHC allotypes.
    Bordner AJ; Mittelmann HD
    BMC Bioinformatics; 2010 Sep; 11():482. PubMed ID: 20868497
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel structural features of the human histocompatibility molecules HLA-DQ as revealed by modeling based on the published structure of the related molecule HLA-DR.
    Paliakasis K; Routsias J; Petratos K; Ouzounis C; Kokkinidis M; Papadopoulos GK
    J Struct Biol; 1996; 117(2):145-63. PubMed ID: 8931340
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structures of an MHC class II molecule with covalently bound single peptides.
    Fremont DH; Hendrickson WA; Marrack P; Kappler J
    Science; 1996 May; 272(5264):1001-4. PubMed ID: 8638119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structural analysis of two HLA-DR-presented autoantigenic epitopes: crucial role of peripheral but not central peptide residues for T-cell receptor recognition.
    De Oliveira DB; Harfouch-Hammoud E; Otto H; Papandreou NA; Stern LJ; Cohen H; Boehm BO; Bach J; Caillat-Zucman S; Walk T; Jung G; Eliopoulos E; Papadopoulos GK; van Endert PM
    Mol Immunol; 2000 Oct; 37(14):813-25. PubMed ID: 11257303
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Conformational variation of surface class II MHC proteins during myeloid dendritic cell differentiation accompanies structural changes in lysosomal MIIC.
    Potolicchio I; Chitta S; Xu X; Fonseca D; Crisi G; Horejsi V; Strominger JL; Stern LJ; Raposo G; Santambrogio L
    J Immunol; 2005 Oct; 175(8):4935-47. PubMed ID: 16210595
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural basis for the binding of an immunodominant peptide from myelin basic protein in different registers by two HLA-DR2 proteins.
    Li Y; Li H; Martin R; Mariuzza RA
    J Mol Biol; 2000 Nov; 304(2):177-88. PubMed ID: 11080454
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The HLA-DRB1 locus as a genetic component in giant cell arteritis. Mapping of a disease-linked sequence motif to the antigen binding site of the HLA-DR molecule.
    Weyand CM; Hicok KC; Hunder GG; Goronzy JJ
    J Clin Invest; 1992 Dec; 90(6):2355-61. PubMed ID: 1469092
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Shared molecular amino acid signature in the HLA-DR peptide binding pocket predisposes to both autoimmune diabetes and thyroiditis.
    Menconi F; Osman R; Monti MC; Greenberg DA; Concepcion ES; Tomer Y
    Proc Natl Acad Sci U S A; 2010 Sep; 107(39):16899-903. PubMed ID: 20837527
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Self-peptides from four HLA-DR alleles share hydrophobic anchor residues near the NH2-terminal including proline as a stop signal for trimming.
    Kropshofer H; Max H; Halder T; Kalbus M; Muller CA; Kalbacher H
    J Immunol; 1993 Nov; 151(9):4732-42. PubMed ID: 8409432
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evolutionary conservation of major histocompatibility complex-DR/peptide/T cell interactions in primates.
    Geluk A; Elferink DG; Slierendregt BL; van Meijgaarden KE; de Vries RR; Ottenhoff TH; Bontrop RE
    J Exp Med; 1993 Apr; 177(4):979-87. PubMed ID: 8459225
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Editing of the HLA-DR-peptide repertoire by HLA-DM.
    Kropshofer H; Vogt AB; Moldenhauer G; Hammer J; Blum JS; Hämmerling GJ
    EMBO J; 1996 Nov; 15(22):6144-54. PubMed ID: 8947036
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HLA-DM targets the hydrogen bond between the histidine at position beta81 and peptide to dissociate HLA-DR-peptide complexes.
    Narayan K; Chou CL; Kim A; Hartman IZ; Dalai S; Khoruzhenko S; Sadegh-Nasseri S
    Nat Immunol; 2007 Jan; 8(1):92-100. PubMed ID: 17143275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.